You are here

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Brussels, , B-1070 Belgium
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Ulcerative Colitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A positive histological diagnosis of UC ≥3 months prior to entry into the study. If a
histological diagnosis is not available but all signs and symptoms suggest UC, the
subject's eligibility should be discussed with Pfizer.

- Active UC as defined by a score of ≥6 on the Mayo score.

- An endoscopic (by flexible sigmoidoscopy) sub-score of ≥2 on the Mayo score determined
within 7 days of first dosing.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with UC, which is confined to a proctitis on a flexible sigmoidoscopy.

- Subjects who have had surgery as a treatment for UC or are likely to require surgery
within the duration of the study.

- Subjects displaying clinical signs of ischemic colitis.

NCT00928681
Pfizer
Completed
A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Ulcerative Colitis
NCT03281304
All Genders
18+
Years
Multiple Sites
Ulcerative Colitis
NCT03269695
All Genders
18+
Years
Multiple Sites
Crohn Desease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
NCT02925338
All Genders
6+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now